· Venture Capital Tracker · investment-strategies  · 1 min read

Century Health's $5M Seed: 97% Clinical Abstraction Accuracy Is the Headline That Matters

Century Health raised $5M seed in NYC — CHARM model hits 97% accuracy on clinical data abstraction for life sciences R&D.

Century Health raised $5M seed in NYC — CHARM model hits 97% accuracy on clinical data abstraction for life sciences R&D.

VCT data record

Funding event facts

Source-backed financing and transaction details. Unknown terms remain undisclosed rather than estimated.

Century Health raises $5M seed

Event type
Funding Round
Event date
May 19, 2026
Stage / label
Seed
Amount
$5M
Confidence
Company Disclosed

Company / target: Century Health

Lead: Origin Ventures

Participants: InnovateHealth Ventures , 25madison , Next Play Ventures , 2048 Ventures , Alumni Ventures

Sources: prnewswire.com

Life sciences doesn’t need another chatbot. It needs clean clinical data. Century Health raised $5M seed because their abstraction model reportedly hits 97% accuracy vs expert judgment.

What they actually do

Apply AI to real-world clinical data — structuring charts, notes, and specialty provider data so pharma can run drug development, market access, and outcomes research faster.

Why accuracy is the whole game

Bad abstraction = bad trials = regulatory risk. Founders who lead with “AI” lose. Founders who lead with validated accuracy on clinician-labeled gold sets win seed rounds in 2026.

Investor map

Origin Ventures (lead), InnovateHealth, 25madison, Next Play, 2048, Alumni — plus angels including Zorba Lieberman (Citeline founder) and specialty clinicians.

Practical takeaway

NYC healthtech seed is funding data infrastructure with clinical rigor, not wellness wrappers. Show your eval methodology before your pitch deck animation.

Sources

  1. PR Newswire: https://www.prnewswire.com/news-releases/century-health-raises-5m-seed-round-as-ai-powered-platform-achieves-97-accuracy-in-clinical-data-abstraction-302776170.html
  2. VC News Daily: https://vcnewsdaily.com/

Follow Venture Capital Tracker in Google

Add VCT as a preferred source to make our venture-capital coverage easier to find in Google Search.

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

Frequently Asked Questions

Common questions about this topic

Research the entities in this story

Persistent profiles connect this article to the companies and investors it discusses.

Back to Blog

Recommended next

Browse all research »